CT attenuation also affected by BMI and blood cortisol levels.
Unenhanced CT attenuation in adrenal adenoma (AA) can be affected by lipid-metabolism-related factors, according to a study published in the journal European Radiology.
Researchers from Japan sought to determine if lipid metabolism-related factors regulated unenhanced CT attenuation in AA. A total of 36 with surgically proven AAs participated in the study. The underlying diseases in the group were:
The researchers measured unenhanced CT attenuation of the AAs and the liver. Pathologically, clear cell ratio (CCR) constituting each AA was qualitatively assessed. The researchers also obtained clinical data including tumor diameter, body mass index (BMI), hemoglobin A1c, triglyceride, total cholesterol, blood cortisol and plasma aldosterone levels were also obtained.
Related article: Fasting Before Contrast-Enhanced CT May Not Be Necessary for Some Patients
The results showed that all patients demonstrated a significant correlation between CT attenuation and each of CCR, BMI and blood cortisol levels. The 24 patients with primary aldosteronism and 1 with non-functioning AA also showed a significant correlation between CT attenuation and CCR or BMI.
The researchers concluded that lipid-metabolism-related factors including BMI and blood cortisol levels can affect unenhanced CT attenuation of AA in addition to pathological factors.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
2 Commerce Drive
Cranbury, NJ 08512